Document is current
Any future updates will be listed below
-
Authors
Christenson, Peter R.
Jeong, Hyeonjeong
Ahn, Hyerim
Li, Manci
Rowden, Gage
Shoemaker, Rachel L.
Larsen, Peter A.
Park, Hye Yoon
Oh, Sang-Hyun
-
Funding
Funding for this research was provided by:
Momental Foundation (Mistletoe Research Fellowship)
State of Minnesota (LCCMR)
State of Minnesota (LCCMR)
State of Minnesota (LCCMR)
State of Minnesota (LCCMR)
State of Minnesota (LCCMR)
State of Minnesota (LCCMR)
University of Minnesota (Startup)
University of Minnesota (Startup)
University of Minnesota (Startup)
University of Minnesota (Startup)
- License Information
-
More Information
Article History
Received: 14 November 2023
Accepted: 9 April 2024
First Online: 26 June 2024
Competing interests
: The authors declare no competing non-financial interests but the following Competing Financial Interests: P.A.L. and S.-H.O. are co-founders and stockowners of Priogen Corp, a diagnostic company specializing in the ultra-sensitive detection of pathogenic proteins associated with prion and protein-misfolding diseases. The University of Minnesota licensed patent applications to Priogen Corp.
